Introduction: Leishmaniasis is one of the six infectious diseases emphasized by the World Health Organization. Mehran and Dehloran cities in the south of Ilam province are endemic centers of cutaneous leishmaniosis in the country. Ilam Province, having near to 420 km common border with Iraq, is exposed to many zoonotic and tropical diseases, including Cutaneous leishmaniasis. Therefore, prevention, early diagnosis and treatment are essential. The registration program is an inseparable and necessary component of comprehensive patient care systems, which can be used as a tool to show the status of the disease. By providing sufficient data, this program has a useful role for managers to use in health care planning. Registry is a necessary component of comprehensive patient care systems, which can be used as a tool to show the status of the disease, which is called follow-up.
Material & Methods: The aim of Cutaneous leishmaniasis registration program in the endemic areas of Ilam province is collection and comparing the correct methods of diagnosis disease with the common one (microscopy) and determining the number of errors made by laboratory experts in the form of a cross-sectional study from May 2018 to august It is 2020.
Findings: By using molecular tests (PCR) to 10% of all positive slides received from Dehloran and Mehran cities, about 5% were false positives, and 28% of all negative slides collected was false negative. It should be mentioned that the implementation of the registration program in Ilam province during the epidemic of corona disease.
Discussion & Conclusion: According to the findings of this study and the importance of the disease due to its endemicity in the southern part of Ilam province, the presence of increasing prevalence of the disease in the past years, the relation between of the traffic of Arbain Hosseini pilgrims with the period of transmission of the disease, mental and physical complications caused by the disease, it is recommended to ensure the referral diagnosis reports of health and laboratory experts, and apply the correct method of diagnosis and reporting, elimination of suspicious, positive and false negative result, and start a molecular diagnosis center, that can help patients be followed up with the correct diagnosis until the of recovery of the treatment period.